AstraZeneca PLC (AZN) reports an 11% revenue increase, driven by oncology and biopharmaceuticals, while navigating R&D ...

AstraZeneca stock bounded into a buy zone Thursday after sales of its cancer drugs beat Wall Street's expectations by about 5 ...

CEO warns continent’s advantage in the industry could fade as companies build new high-tech factories elsewhere ...

Investing.com -- AstraZeneca PLC (ST:AZN) announced Tuesday that its drug Koselugo (selumetinib) has received European Union ...

Q3 revenues surpassed $15 billion thanks to soaring sales of cancer drugs. CEO Pascal Soriot told Market Sunrise host Ramzan ...

ALMAC Diagnostic Services, a division of the Craigavon-headquartered Almac Group, has signed a master collaboration agreement (MCA) with global pharmaceutical giant AstraZeneca to develop and ...

AstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS) beat the Zacks Consensus Estimate of 86 cents and our model estimate of 85 cents. Core earnings of $1 ...

Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...

IGI Laboratories Inc., a Buena-based generic drugmaker, announced Thursday that it has acquired the regulatory rights to 18 drug products from AstraZeneca.Seventeen of the 18 drugs were marketed, IGI ...

AstraZeneca chief exec Pascal Soriot (pictured) said Britain should be trying to attract cash from the pharmaceutical sector ...

AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, ...

WHITEHOUSE STATION, N.J., March 1, 2010 - Merck & Co., Inc. announced today that it has been advised by AstraZeneca PLC that it will exercise the option to obtain Merck's interest in AstraZeneca's non ...